Showing results (1-10 of 436) with videos related to
Sort By:
Pageof 44
Investigational New Drugs|March 6, 2009
Cyclin-dependent kinase inhibitors as potential targeted anticancer agentsIvan Diaz-Padilla, Lillian L Siu, Ignacio DuranExpert Opinion on Investigational Drugs|March 12, 2011
Brivanib alaninate for cancerIvan Diaz-Padilla, Lillian L SiuCancer Treatment Reviews|March 3, 2012
Biologic rationale and clinical activity of mTOR inhibitors in gynecological cancerIvan Diaz-Padilla, Ignacio Duran, Blaise A Clarke, et al.Blood Cancer Discovery|November 13, 2025
The Global State of Blood Cancers: An Ongoing ChallengeLillian L Siu, Cancer Discovery|April 1, 2026
Precision, Partnership, Purpose: Advancing Cancer Science to Save Lives GloballyLillian L SiuFuture Oncology (London, England)|April 6, 2011
Epothilones in the treatment of ovarian cancerIvan Diaz-Padilla, Amit M OzaClinical Medicine Insights. Oncology|June 12, 2018
Precision Medicine in Head and Neck Cancer: Myth or Reality?Eoghan Malone, Lillian L SiuCurrent Opinion in Oncology|March 12, 2015
Cancer genomics: the challenge of drug accessibilityJeremy Lewin, Lillian L SiuCurrent Pharmaceutical Design|October 9, 2002
Rationale for Ras and raf-kinase as a target for cancer therapeuticsMichelle Nottage, Lillian L SiuPageof 44